Changes in the Levels of Beta-thromboglobulin and Inflammatory Mediators during Extracorporeal Membrane Oxygenation Support

Abstract

Our data suggest that ECMO use may not affect platelet activation during the first 3 days of ECMO. Plasma beta-TG levels may allow assessment of the time-dependent extent of ECMO-induced platelet dysfunction in patients with acute respiratory failure.